Advertisement
Screener

Vaccinex, Inc. (VCNX) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

1.5 / 5 stars · 12/40 Roast Me

Vaccinex, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

Vaccinex, Inc. (VCNX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 73.91 thousand shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.

Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2025-04-15

  • Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-12-31 was 0.00 shares.
  • Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was 0.00 shares.
  • Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-06-30 was 68.54K shares, a 90.93% decline year-over-year.
  • Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-03-31 was 5.37K shares, a 99.13% decline year-over-year.
  • Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 73.91K shares, a 1030.93% increase from fiscal 2023.
  • Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 6.54K shares, a 114.54% increase from fiscal 2022.
  • Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 3.05K shares, a 99.12% decline from fiscal 2021.
  • Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 346.94K shares, a 4.87% increase from fiscal 2020.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed
2024-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15
0.00 shares
derived: sum of 2 quarters · filed 2025-04-15
68.54K shares
derived: sum of 3 quarters · filed 2025-04-15
73.91K shares
10-K · filed 2025-04-15
2024-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
68.54K shares
derived: sum of 2 quarters · filed 2024-11-14
73.91K shares
10-Q · filed 2024-11-14
-11.25K shares
derived: sum of 4 quarters · filed 2025-04-15
2024-06-3068.54K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
73.91K shares
10-Q · filed 2024-08-14
-11.25K shares
derived: sum of 3 quarters · filed 2025-04-15
-1.30M shares
derived: sum of 4 quarters · filed 2025-04-15
2024-03-315.37K shares
10-Q · filed 2024-05-15
-79.79K shares
derived: sum of 2 quarters · filed 2025-04-15
-1.36M shares
derived: sum of 3 quarters · filed 2025-04-15
-608.21K shares
derived: sum of 4 quarters · filed 2025-04-15
2023-12-31-85.15K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15
-1.37M shares
derived: sum of 2 quarters · filed 2025-04-15
-613.57K shares
derived: sum of 3 quarters · filed 2025-04-15
6.54K shares
10-K · filed 2025-04-15
2023-09-30-1.28M shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
-528.42K shares
derived: sum of 2 quarters · filed 2023-11-13
91.69K shares
10-Q · filed 2023-11-13
-517.89K shares
derived: sum of 4 quarters · filed 2024-04-25
2023-06-30755.45K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
1.38M shares
10-Q · filed 2023-08-14
765.98K shares
derived: sum of 3 quarters · filed 2024-04-25
792.24K shares
derived: sum of 4 quarters · filed 2024-04-25
2023-03-31620.11K shares
10-Q · filed 2023-05-15
10.53K shares
derived: sum of 2 quarters · filed 2024-04-25
36.79K shares
derived: sum of 3 quarters · filed 2024-04-25
613.12K shares
derived: sum of 4 quarters · filed 2024-04-25
2022-12-31-609.58K shares
derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-04-25
-583.32K shares
derived: sum of 2 quarters · filed 2024-04-25
-6.99K shares
derived: sum of 3 quarters · filed 2024-04-25
3.05K shares
10-K/A · filed 2024-04-25
642.48K shares
10-K · filed 2023-03-31
2022-09-3026.26K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
602.59K shares
derived: sum of 2 quarters · filed 2022-11-14
612.63K shares
10-Q · filed 2022-11-14
625.48K shares
derived: sum of 4 quarters · filed 2023-03-31
2022-06-30576.33K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
586.37K shares
10-Q · filed 2022-08-15
599.22K shares
derived: sum of 3 quarters · filed 2023-03-31
605.46K shares
derived: sum of 4 quarters · filed 2023-03-31
2022-03-3110.03K shares
10-Q · filed 2022-05-16
22.89K shares
derived: sum of 2 quarters · filed 2023-03-31
29.12K shares
derived: sum of 3 quarters · filed 2023-03-31
346.44K shares
derived: sum of 4 quarters · filed 2023-03-31
2021-12-3112.86K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
19.09K shares
derived: sum of 2 quarters · filed 2023-03-31
336.41K shares
derived: sum of 3 quarters · filed 2023-03-31
346.94K shares
10-K · filed 2023-03-31
2021-09-306.23K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08
323.55K shares
derived: sum of 2 quarters · filed 2021-11-08
334.09K shares
10-Q · filed 2021-11-08
340.63K shares
derived: sum of 4 quarters · filed 2022-03-31
2021-06-30317.32K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
327.86K shares
10-Q · filed 2021-08-16
334.40K shares
derived: sum of 3 quarters · filed 2022-03-31
392.03K shares
derived: sum of 4 quarters · filed 2022-03-31
2021-03-3110.54K shares
10-Q · filed 2021-05-17
17.08K shares
derived: sum of 2 quarters · filed 2022-03-31
74.71K shares
derived: sum of 3 quarters · filed 2022-03-31
287.64K shares
derived: sum of 4 quarters · filed 2022-03-31
2020-12-316.54K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
64.17K shares
derived: sum of 2 quarters · filed 2022-03-31
277.11K shares
derived: sum of 3 quarters · filed 2022-03-31
330.85K shares
10-K · filed 2022-03-31
2020-09-3057.63K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13
270.56K shares
derived: sum of 2 quarters · filed 2020-11-13
324.30K shares
10-Q · filed 2020-11-13
331.97K shares
derived: sum of 4 quarters · filed 2021-03-31
2020-06-30212.94K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14
266.67K shares
10-Q · filed 2020-08-14
274.35K shares
derived: sum of 3 quarters · filed 2021-03-31
282.06K shares
derived: sum of 4 quarters · filed 2021-03-31
2020-03-3153.74K shares
10-Q · filed 2020-05-14
61.41K shares
derived: sum of 2 quarters · filed 2021-03-31
69.12K shares
derived: sum of 3 quarters · filed 2021-03-31
121.70K shares
derived: sum of 4 quarters · filed 2021-03-31
2019-12-317.67K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
15.39K shares
derived: sum of 2 quarters · filed 2021-03-31
67.96K shares
derived: sum of 3 quarters · filed 2021-03-31
203.94K shares
10-K · filed 2021-03-31
2019-09-307.71K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
60.29K shares
derived: sum of 2 quarters · filed 2019-11-12
196.26K shares
10-Q · filed 2019-11-12
198.26K shares
derived: sum of 4 quarters · filed 2020-03-09
2019-06-3052.58K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
188.55K shares
10-Q · filed 2019-08-14
190.55K shares
derived: sum of 3 quarters · filed 2020-03-09
190.55K shares
derived: sum of 4 quarters · filed 2020-03-09
2019-03-31135.97K shares
10-Q · filed 2019-05-15
137.97K shares
derived: sum of 2 quarters · filed 2020-03-09
137.97K shares
derived: sum of 3 quarters · filed 2020-03-09
2018-12-312.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09
2.00K shares
derived: sum of 2 quarters · filed 2020-03-09
30.00K shares
10-K · filed 2020-03-09
2018-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
28.00K shares
10-Q · filed 2018-11-13
2018-06-3028.00K shares
10-Q · filed 2018-08-14
2017-12-3133.98K shares
10-K · filed 2019-03-13
2017-06-300.00 shares
10-Q · filed 2018-08-14